Brigham study finds low heart attack risk in Bristol-Myers/AstraZeneca diabetes drug
September 03, 2013 at 13:03 PM EDT
A study conducted at Brigham and Women’s Hospital has shown that the diabetes drug Onglyza does not raise the risk for heart attacks...
